Atrion (ATRI) Hits New 12-Month High at $815.00

Atrion Co. (NASDAQ:ATRI) shares reached a new 52-week high during trading on Friday . The company traded as high as $815.00 and last traded at $814.57, with a volume of 12495 shares traded. The stock had previously closed at $802.30.

A number of research analysts have recently commented on the stock. BidaskClub cut shares of Atrion from a “buy” rating to a “hold” rating in a research report on Thursday. ValuEngine raised shares of Atrion from a “hold” rating to a “buy” rating in a research report on Monday, February 4th.

The stock has a market capitalization of $1.48 billion, a P/E ratio of 43.30 and a beta of 0.43.

The company also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Stockholders of record on Friday, March 15th will be given a dividend of $1.35 per share. The ex-dividend date of this dividend is Thursday, March 14th. This represents a $5.40 dividend on an annualized basis and a dividend yield of 0.66%.

Several hedge funds and other institutional investors have recently bought and sold shares of ATRI. First Trust Advisors LP lifted its position in shares of Atrion by 279.4% during the third quarter. First Trust Advisors LP now owns 5,034 shares of the medical instruments supplier’s stock worth $3,498,000 after purchasing an additional 3,707 shares in the last quarter. Victory Capital Management Inc. raised its holdings in Atrion by 46.7% in the third quarter. Victory Capital Management Inc. now owns 748 shares of the medical instruments supplier’s stock valued at $520,000 after acquiring an additional 238 shares in the last quarter. SG Americas Securities LLC raised its holdings in Atrion by 682.1% in the third quarter. SG Americas Securities LLC now owns 1,924 shares of the medical instruments supplier’s stock valued at $1,337,000 after acquiring an additional 1,678 shares in the last quarter. Rhumbline Advisers raised its holdings in Atrion by 29.9% in the third quarter. Rhumbline Advisers now owns 5,479 shares of the medical instruments supplier’s stock valued at $3,807,000 after acquiring an additional 1,262 shares in the last quarter. Finally, Thomson Horstmann & Bryant Inc. raised its holdings in Atrion by 1.0% in the third quarter. Thomson Horstmann & Bryant Inc. now owns 14,636 shares of the medical instruments supplier’s stock valued at $10,169,000 after acquiring an additional 145 shares in the last quarter. 61.74% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Atrion (ATRI) Hits New 12-Month High at $815.00” was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.com-unik.info/2019/03/15/atrion-atri-hits-new-12-month-high-at-815-00.html.

Atrion Company Profile (NASDAQ:ATRI)

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Read More: Average Daily Trade Volume – ADTV

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit